These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 15105268)

  • 1. Manganese-induced parkinsonism and Parkinson's disease.
    Olanow CW
    Ann N Y Acad Sci; 2004 Mar; 1012():209-23. PubMed ID: 15105268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.
    Kwakye GF; Paoliello MM; Mukhopadhyay S; Bowman AB; Aschner M
    Int J Environ Res Public Health; 2015 Jul; 12(7):7519-40. PubMed ID: 26154659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonism induced by chronic manganese intoxication--an experience in Taiwan.
    Huang CC
    Chang Gung Med J; 2007; 30(5):385-95. PubMed ID: 18062168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]FDOPA PET and clinical features in parkinsonism due to manganism.
    Racette BA; Antenor JA; McGee-Minnich L; Moerlein SM; Videen TO; Kotagal V; Perlmutter JS
    Mov Disord; 2005 Apr; 20(4):492-496. PubMed ID: 15648057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Prange S; Hermier M; Danaila T; Laurencin C; Thobois S
    Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for a relationship between manganese and welding and Parkinson's disease.
    Jankovic J
    Neurology; 2005 Jun; 64(12):2021-8. PubMed ID: 15985567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese neurotoxicity: a review of clinical features, imaging and pathology.
    Pal PK; Samii A; Calne DB
    Neurotoxicology; 1999; 20(2-3):227-38. PubMed ID: 10385886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PET or SPECT for postsynaptic nerve cells in the striatum can possibly contribute to better insight to manganese-induced parkinsonism].
    Ostergaard K
    Ugeskr Laeger; 2006 Feb; 168(6):598-9; author reply 599-600. PubMed ID: 16476233
    [No Abstract]   [Full Text] [Related]  

  • 10. The neuropathology of manganese-induced Parkinsonism.
    Perl DP; Olanow CW
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):675-82. PubMed ID: 17882011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
    Kim Y; Kim JM; Kim JW; Yoo CI; Lee CR; Lee JH; Kim HK; Yang SO; Chung HK; Lee DS; Jeon B
    Mov Disord; 2002 May; 17(3):568-75. PubMed ID: 12112209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse.
    de Bie RM; Gladstone RM; Strafella AP; Ko JH; Lang AE
    Arch Neurol; 2007 Jun; 64(6):886-9. PubMed ID: 17562938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of the combined use of
    Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
    Acta Radiol; 2019 Feb; 60(2):230-238. PubMed ID: 29804474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study.
    Selikhova M; Fedoryshyn L; Matviyenko Y; Komnatska I; Kyrylchuk M; Krolicki L; Friedman A; Taylor A; Jäger HR; Lees A; Sanotsky Y
    Mov Disord; 2008 Nov; 23(15):2224-31. PubMed ID: 18785245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic implications of manganese neurotoxicity.
    Weiss B
    Neurotoxicology; 2006 May; 27(3):362-8. PubMed ID: 15936082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic utility of positron emission tomography for parkinsonism after chronic manganese exposure].
    Abe Y; Kachi T; Kato T; Ito K; Yanagisawa N; Sobue G
    Rinsho Shinkeigaku; 1999 Jul; 39(7):693-9. PubMed ID: 10548904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Essential points to differentiate various diseases causing parkinsonism].
    Kuzuhara S
    Nihon Rinsho; 2000 Oct; 58(10):2049-53. PubMed ID: 11068445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter SPECT of a liver cirrhotic with atypical parkinsonism.
    Kim J; Kim JM; Kim YK; Shin JW; Choi SH; Kim SE; Kim Y
    Ind Health; 2007 Jun; 45(3):497-500. PubMed ID: 17634700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of manganese parkinsonism].
    LEVIN SL; SUKHOTINA KI
    Gig Sanit; 1956 Jun; 21(6):29-33. PubMed ID: 13344937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.